Cidara Therapeutics surged 250% on strong CD388 trial results and solid financials, but faces Phase 3 challenges ahead. See ...

Technologies with the greatest potential for Poland include advanced materials, quantum communication, and biotechnologies ...

In the United States, health mandates traditionally have been tempered by the need to allow people to make personal choices.

Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

Beijing-based biotech unicorn METiS TechBio has rolled out what it calls the world's first AI-powered nano-delivery platform, ...

Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

Bacteriophages, or phages for short, are viruses that infect bacteria. Using phages therapeutically could be very useful in ...

Agencies and communications professionals involved in the healthcare sector have a golden opportunity to leverage our ...

Moderna, Inc. (NASDAQ:MRNA) is the ill-fated vaccine company that has continued to struggle after the COVID-19 pandemic’s end ...

At the hearing, Kennedy stood by his decision to cut US$500 million in HHS funding for 22 research contracts on mRNA vaccine technology. HHS has said it will instead pour these funds into research on ...